234 related articles for article (PubMed ID: 15035641)
1. Phthalocyanine tetrasulfonates affect the amyloid formation and cytotoxicity of alpha-synuclein.
Lee EN; Cho HJ; Lee CH; Lee D; Chung KC; Paik SR
Biochemistry; 2004 Mar; 43(12):3704-15. PubMed ID: 15035641
[TBL] [Abstract][Full Text] [Related]
2. Copper(II)-induced self-oligomerization of alpha-synuclein.
Paik SR; Shin HJ; Lee JH; Chang CS; Kim J
Biochem J; 1999 Jun; 340 ( Pt 3)(Pt 3):821-8. PubMed ID: 10359669
[TBL] [Abstract][Full Text] [Related]
3. Review: formation and properties of amyloid-like fibrils derived from alpha-synuclein and related proteins.
El-Agnaf OM; Irvine GB
J Struct Biol; 2000 Jun; 130(2-3):300-9. PubMed ID: 10940234
[TBL] [Abstract][Full Text] [Related]
4. Metal-catalyzed oxidation of alpha-synuclein in the presence of Copper(II) and hydrogen peroxide.
Paik SR; Shin HJ; Lee JH
Arch Biochem Biophys; 2000 Jun; 378(2):269-77. PubMed ID: 10860544
[TBL] [Abstract][Full Text] [Related]
5. Interaction of the molecular chaperone alphaB-crystallin with alpha-synuclein: effects on amyloid fibril formation and chaperone activity.
Rekas A; Adda CG; Andrew Aquilina J; Barnham KJ; Sunde M; Galatis D; Williamson NA; Masters CL; Anders RF; Robinson CV; Cappai R; Carver JA
J Mol Biol; 2004 Jul; 340(5):1167-83. PubMed ID: 15236975
[TBL] [Abstract][Full Text] [Related]
6. Binding Modes of Phthalocyanines to Amyloid β Peptide and Their Effects on Amyloid Fibril Formation.
Valiente-Gabioud AA; Riedel D; Outeiro TF; Menacho-Márquez MA; Griesinger C; Fernández CO
Biophys J; 2018 Mar; 114(5):1036-1045. PubMed ID: 29539391
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro.
Hashimoto M; Hsu LJ; Xia Y; Takeda A; Sisk A; Sundsmo M; Masliah E
Neuroreport; 1999 Mar; 10(4):717-21. PubMed ID: 10208537
[TBL] [Abstract][Full Text] [Related]
8. Differential copper binding to alpha-synuclein and its disease-associated mutants affect the aggregation and amyloid formation.
Ranjan P; Ghosh D; Yarramala DS; Das S; Maji SK; Kumar A
Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):365-374. PubMed ID: 27916677
[TBL] [Abstract][Full Text] [Related]
9. Heparin and other glycosaminoglycans stimulate the formation of amyloid fibrils from alpha-synuclein in vitro.
Cohlberg JA; Li J; Uversky VN; Fink AL
Biochemistry; 2002 Feb; 41(5):1502-11. PubMed ID: 11814343
[TBL] [Abstract][Full Text] [Related]
10. Forcing nonamyloidogenic beta-synuclein to fibrillate.
Yamin G; Munishkina LA; Karymov MA; Lyubchenko YL; Uversky VN; Fink AL
Biochemistry; 2005 Jun; 44(25):9096-107. PubMed ID: 15966733
[TBL] [Abstract][Full Text] [Related]
11. A strategy for designing inhibitors of alpha-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders.
El-Agnaf OM; Paleologou KE; Greer B; Abogrein AM; King JE; Salem SA; Fullwood NJ; Benson FE; Hewitt R; Ford KJ; Martin FL; Harriott P; Cookson MR; Allsop D
FASEB J; 2004 Aug; 18(11):1315-7. PubMed ID: 15180968
[TBL] [Abstract][Full Text] [Related]
12. More than just two peas in a pod: common amyloidogenic properties of tau and alpha-synuclein in neurodegenerative diseases.
Lee VM; Giasson BI; Trojanowski JQ
Trends Neurosci; 2004 Mar; 27(3):129-34. PubMed ID: 15036877
[TBL] [Abstract][Full Text] [Related]
13. Lipid interaction of alpha-synuclein during the metal-catalyzed oxidation in the presence of Cu2+ and H2O2.
Lee EN; Lee SY; Lee D; Kim J; Paik SR
J Neurochem; 2003 Mar; 84(5):1128-42. PubMed ID: 12603836
[TBL] [Abstract][Full Text] [Related]
14. Differential cytotoxicity of human wild type and mutant alpha-synuclein in human neuroblastoma SH-SY5Y cells in the presence of dopamine.
Moussa CE; Wersinger C; Tomita Y; Sidhu A
Biochemistry; 2004 May; 43(18):5539-50. PubMed ID: 15122920
[TBL] [Abstract][Full Text] [Related]
15. Dependence of alpha-synuclein aggregate morphology on solution conditions.
Hoyer W; Antony T; Cherny D; Heim G; Jovin TM; Subramaniam V
J Mol Biol; 2002 Sep; 322(2):383-93. PubMed ID: 12217698
[TBL] [Abstract][Full Text] [Related]
16. Structural and mechanistic basis behind the inhibitory interaction of PcTS on alpha-synuclein amyloid fibril formation.
Lamberto GR; Binolfi A; Orcellet ML; Bertoncini CW; Zweckstetter M; Griesinger C; Fernández CO
Proc Natl Acad Sci U S A; 2009 Dec; 106(50):21057-62. PubMed ID: 19948969
[TBL] [Abstract][Full Text] [Related]
17. Oxidized glutathione stimulated the amyloid formation of alpha-synuclein.
Paik SR; Lee D; Cho HJ; Lee EN; Chang CS
FEBS Lett; 2003 Feb; 537(1-3):63-7. PubMed ID: 12606032
[TBL] [Abstract][Full Text] [Related]
18. alpha-Synuclein implicated in Parkinson's disease catalyses the formation of hydrogen peroxide in vitro.
Turnbull S; Tabner BJ; El-Agnaf OM; Moore S; Davies Y; Allsop D
Free Radic Biol Med; 2001 May; 30(10):1163-70. PubMed ID: 11369507
[TBL] [Abstract][Full Text] [Related]
19. Clearance of alpha-synuclein oligomeric intermediates via the lysosomal degradation pathway.
Lee HJ; Khoshaghideh F; Patel S; Lee SJ
J Neurosci; 2004 Feb; 24(8):1888-96. PubMed ID: 14985429
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of Cu
Lorentzon E; Kumar R; Horvath I; Wittung-Stafshede P
Biometals; 2020 Jun; 33(2-3):97-106. PubMed ID: 32170541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
